These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 19070943

  • 1. Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.
    Rakić GM, Grgurić-Sipka S, Kaluderović GN, Gómez-Ruiz S, Bjelogrlić SK, Radulović SS, Tesić ZLj.
    Eur J Med Chem; 2009 May; 44(5):1921-5. PubMed ID: 19070943
    [Abstract] [Full Text] [Related]

  • 2. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
    Pantoja E, Gallipoli A, van Zutphen S, Komeda S, Reddy D, Jaganyi D, Lutz M, Tooke DM, Spek AL, Navarro-Ranninger C, Reedijk J.
    J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, cytotoxicity and DNA-binding levels of new type binuclear platinum(II) complexes.
    Zhang J, Li Y, Sun J, Li W, Gong Y, Zheng X, Cui J, Wang R, Wu J.
    Eur J Med Chem; 2009 Nov; 44(11):4772-7. PubMed ID: 19615790
    [Abstract] [Full Text] [Related]

  • 4. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J.
    J Med Chem; 2003 Mar 27; 46(7):1210-9. PubMed ID: 12646031
    [Abstract] [Full Text] [Related]

  • 5. Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity.
    Xue Z, Lin M, Zhu J, Zhang J, Li Y, Guo Z.
    Chem Commun (Camb); 2010 Feb 28; 46(8):1212-4. PubMed ID: 20449253
    [Abstract] [Full Text] [Related]

  • 6. The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines.
    Rakić GM, Grgurić-Šipka S, Kaluđerović GN, Bette M, Filipović L, Aranđelović S, Radulović S, Tešić ZLj.
    Eur J Med Chem; 2012 Sep 28; 55():214-9. PubMed ID: 22858225
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, characterization and biological activity of Pt(II) and Pt(IV) complexes with 5-methyl-5(4-pyridyl)-2,4-imidazolidenedione.
    Bakalova A, Varbanov H, Buyukliev R, Momekov G, Ferdinandov D, Konstantinov S, Ivanov D.
    Eur J Med Chem; 2008 May 28; 43(5):958-65. PubMed ID: 17707952
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, spectroscopy and antiproliferative activity of cis- and trans-platinum(II) complexes with diethyl (pyridin-4-ylmethyl)phosphate. X-ray crystal structure of trans-Pt(II) complex.
    Kalinowska U, Matławska K, Checińska L, Domagała M, Kontek R, Osiecka R, Ochocki J.
    J Inorg Biochem; 2005 Oct 28; 99(10):2024-31. PubMed ID: 16111760
    [Abstract] [Full Text] [Related]

  • 9. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J, Liebeke M, Kaiser M, Bracht K, Olszewski U, Zeillinger R, Hamilton G, Braun D, Bednarski PJ.
    Anticancer Drugs; 2009 Aug 28; 20(7):559-72. PubMed ID: 19491657
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes.
    Zhang J, Liu L, Gong Y, Zheng X, Yang M, Cui J, Shen S.
    Eur J Med Chem; 2009 May 28; 44(5):2322-7. PubMed ID: 18524422
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM, Sarju J, Wagner G.
    J Med Chem; 2008 Jan 10; 51(1):135-41. PubMed ID: 18072719
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, characterization and cytotoxicity of ammine/ethylamine platinum(II) complexes with carboxylates.
    Zhang J, Li Y, Sun J.
    Eur J Med Chem; 2009 Jun 10; 44(6):2758-62. PubMed ID: 19056150
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
    Kovala-Demertzi D, Papageorgiou A, Papathanasis L, Alexandratos A, Dalezis P, Miller JR, Demertzis MA.
    Eur J Med Chem; 2009 Mar 10; 44(3):1296-302. PubMed ID: 18848372
    [Abstract] [Full Text] [Related]

  • 14. Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: synthesis, characterization and antitumour activity.
    Szucová L, Trávnícek Z, Zatloukal M, Popa I.
    Bioorg Med Chem; 2006 Jan 15; 14(2):479-91. PubMed ID: 16198575
    [Abstract] [Full Text] [Related]

  • 15. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR.
    J Inorg Biochem; 2005 Mar 15; 99(3):795-804. PubMed ID: 15708801
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
    Trávnícek Z, Szucová L, Popa I.
    J Inorg Biochem; 2007 Mar 15; 101(3):477-92. PubMed ID: 17208304
    [Abstract] [Full Text] [Related]

  • 17. Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity.
    Grgurić-Sipka S, Ivanović I, Rakić G, Todorović N, Gligorijević N, Radulović S, Arion VB, Keppler BK, Tesić ZLj.
    Eur J Med Chem; 2010 Mar 15; 45(3):1051-8. PubMed ID: 20053483
    [Abstract] [Full Text] [Related]

  • 18. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands.
    Zorbas-Seifried S, Jakupec MA, Kukushkin NV, Groessl M, Hartinger CG, Semenova O, Zorbas H, Kukushkin VY, Keppler BK.
    Mol Pharmacol; 2007 Jan 15; 71(1):357-65. PubMed ID: 17050805
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma.
    Lowe G, Droz AS, Vilaivan T, Weaver GW, Park JJ, Pratt JM, Tweedale L, Kelland LR.
    J Med Chem; 1999 Aug 12; 42(16):3167-74. PubMed ID: 10447962
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, characterization and biological activity of trans-platinum(II) and trans-platinum(IV) complexes with 4-hydroxymethylpyridine.
    Martínez A, Lorenzo J, Prieto MJ, de Llorens R, Font-Bardia M, Solans X, Avilés FX, Moreno V.
    Chembiochem; 2005 Nov 12; 6(11):2068-77. PubMed ID: 16222727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.